Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,956 total articles
GE Aerospace combines high-margin aftermarket revenue, strong free cash flow and targeted manufacturing investments that should translate into durable growth. At a market cap near $305B and free cash flow of $7.26B, the stock carries a premium multiple but has several clear catalysts - expanding MRO programs, defense wins and AI-driven maintenance …
Var Energi is a leveraged exposure to higher oil prices and geopolitical risk. With markets once again pricing Iran-related conflict into crude, this trade idea sets a defined long entry at $3.25, a stop at $2.10 and an initial target at $5.00. The plan leans on near-term oil price upside as a catalyst and uses strict risk control given the politic…
GTA VI is bigger than an earnings beat — it rewrites recurring revenue and engagement for Take-Two. The market is underestimating the degree to which in-game monetization, live-service longevity, and ancillary licensing can extend margins and cash flow. This trade targets a disciplined long with a clearly defined entry, stop and target and a 180-tr…
Voyager Technologies is showing tangible defense revenue momentum and progressing Starlab toward manufacturing after a Commercial Critical Design Review. The stock has pulled back into technical support and carries material upside if NASA awards contracts or Starlab validation continues. We recommend a mid-term long trade with strict risk controls …
Boston Scientific (BSX) is under pressure after a sharp earnings-driven selloff and multiple securities class action filings, but technical oversold conditions, a healthy free cash flow profile ($3.66B), and manageable leverage argue for a measured tactical long. This is a rated-up trade idea: enter around $68.60, stop at $64.00, and target $82.00 …
Amplitude's stock has been punished into the low single digits but the underlying business is showing signs of healthier unit economics: recent quarterly revenue acceleration, notable free cash flow and product-led AI momentum. With a market cap around $900M and $192M of cash plus a $100M buyback authorization, the risk-reward favors a measured lon…
Pfizer offers a compelling short-to-mid-term trade: the stock sits near technical support, yields ~6.3%, and the company produces meaningful free cash flow ($10.375B). With a market cap of roughly $153.4B and an EV/EBITDA of 9.06, the risk-reward for a mid-term rebound is attractive. This note lays out an entry at $26.70, a $30.00 target (45 tradin…
Booking Holdings (BKNG) has been sold off on headlines about AI threats to online travel agencies. Fundamentals remain strong - $135.9B market cap, $9.09B free cash flow, and EPS of $170.62 - while technicals show recent support near $4,000. We upgrade to Buy and propose an actionable long trade with a $4,340 entry, $3,900 stop and $5,900 target ov…
CAREVIEW COMMUNS (CRVW) is an ultralow-priced OTC stock showing renewed momentum and meaningful short interest. This trade idea outlines a mid-term, structured long: entry at current levels, tight stop, and a larger profit target to reflect the speculative upside if volume and short-covering accelerate.
Dollarama (DLMAF) plunged into oversold territory after a sharp post-quarter selloff. The OTC-listed shares show stretched negativity — RSI 26, price below the 10/20/50 SMAs, and very high short-volume on 03/24/2026 — creating a risk-reward setup for a long trade. This idea is tactical: enter near $120, limit downside with a $104 stop, and aim for …
DHT's balance-sheet improvement from recent VLCC sales and the arrival of newbuildings into the spot market materially increases the company's optionality for a large Q2 cash distribution. Shares trade at $18.64 with a market cap near $2.97B and a PE of 13.5; a disciplined mid-term long can capture upside if management leans into a special/boosted …
Santander trades near $11 with a market cap of $160B and a trailing P/E ~10.9. Recent noise around a UK mortgage exposure and legal inquiries has pressured sentiment. Under the surface, a diversified franchise, improving risk-weighted asset mix, and strategic initiatives in payments and digital banking argue for earnings recovery and multiple re-ra…
Micron beat fiscal Q2 estimates handily, but guidance and a heavy capex cadence create a trap for momentum buyers. At roughly $446B market cap and ~19x reported EPS, the stock is richly priced vs cyclical memory risk. This trade idea lays out a mid-term short: enter at $400.01, target $320.00, stop $428.00, horizon 45 trading days.
Azenta's business sits in an expanding biopreservation market, but recent price action, negative earnings, weakening moving averages and elevated short activity signal limited upside near-term. We recommend a tactical short with defined entry, stop and target over a mid-term horizon (45 trading days).
Blue Owl (OWL) has been punished on private credit redemption headlines and short-term liquidity worries. Fundamentals — significant free cash flow, a sub-$10B enterprise value and an oversold technical set-up — argue for a tactical long. This trade lays out exact entry, stop and target with a 45 trading-day horizon and clear risk controls.
Comstock Resources is a pure-play Haynesville gas producer with a compact share structure, attractive EV/EBITDA and clear operational optionality in the Western Haynesville. With natural gas fundamentals improving and technicals showing constructive momentum, we initiate a long trade: entry $21.30, target $28.00, stop $18.50, horizon 180 trading da…
Autoliv’s fundamentals still look healthy on the surface, but 2026 momentum and technicals point to a meaningful downside risk. Low RSI, weakening moving averages, elevated short activity and modest margin/volume upside leave the stock exposed even as valuation appears reasonable. This trade is a tactical mid-term short targeting the $88 area.
Insmed ($139.14) trades at a premium valuation but already owns an approved DPP1 drug with significant peak sales potential and a legacy inhaled antibiotic that could see label expansion. We rate INSM a Strong Buy — entry $140.00, stop $120.00, target $210.00 — for long-term upside if BRINSUPRI adoption continues and ARIKAYCE gains new indications.
Frontline (FRO) is trading near multi-month highs as tanker fundamentals tighten and geopolitical noise keeps freight rates supported. We lay out a mid-term (45 trading days) long trade: enter at $35.50, target $39.50, stop $31.00. Risk is real - freight volatility, oil demand weakness and macro shocks can reverse gains - but the company's recent p…
TTD has cratered with headline risk and agency defections, but revenue growth, margins, cash flow and insider buying argue this sell-off is overshooting. I outline a mid-term (45 trading days) swing trade with strict risk control that captures the most likely path back to normalization while protecting capital if the agency dispute widens.
Palo Alto Networks (PANW) is trading down after a recent pullback despite strong platform positioning, a string of AI/security-related acquisitions and healthy free cash flow. Valuation is rich, but the firm's scale, 119% reported net retention and a $3.57B free cash flow run-rate justify a measured long trade. Entry at $157.00, stop at $142.00, an…
Palantir's pullback in a volatile tape is a chance to take a defined-risk long. Strong growth, improving profitability and cash generation justify a tactical long for traders willing to accept valuation risk. Trade plan, catalysts and contingencies provided.
Pixelworks is a tiny semiconductor/IC designer trading at roughly $5.70 with an enterprise value near $21.7M and market cap in the low tens of millions. With meaningful cash on the balance sheet, a tightening short-interest profile and a history of narrowing losses, there is a straightforward trade: buy into potential restructuring or strategic-alt…
Affirm (AFRM) is a contrarian fintech long. The company is profitable, generating meaningful free cash flow and growing gross merchandise volume, yet the stock trades well below prior highs and carries a valuation that discounts durable growth. I recommend entering at $45.00 with a $65.00 target and $37.50 stop, sized for a long-term horizon (180 t…
Parsons is trading near its 52-week low after a Q4 miss, but fundamentals and sector tailwinds argue for upside. At roughly $5.45B market cap, positive free cash flow, modest leverage and recent acquisitions give the company optionality into a wave of defense and infrastructure spend. Technicals are oversold and short interest is moderate; the trad…
